94 results
FWP
ONCT
Oncternal Therapeutics Inc
27 Aug 20
Free writing prospectus
5:26pm
that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment
8-K
EX-99.2
ONCT
Oncternal Therapeutics Inc
19 Nov 20
Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering
5:06pm
to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 7,258,065
8-K
EX-99.1
ONCT
Oncternal Therapeutics Inc
19 Nov 20
Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering
5:06pm
into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 6,451,613
FWP
ONCT
Oncternal Therapeutics Inc
17 Nov 20
Free writing prospectus
5:27pm
commitment basis 6,451,613 shares of common stock of the Company, at a price to the public of $3.10 per share, less underwriting discounts and commissions
FWP
ONCT
Oncternal Therapeutics Inc
10 Dec 20
Free writing prospectus
12:00am
commitment basis 8,888,889 shares of common stock of the Company, at a price to the public of $4.50 per share, less underwriting discounts and commissions
8-K
EX-99.2
sk6h2x o2yk
11 Dec 20
Oncternal Therapeutics Announces $40.0 Million Bought Deal Offering
6:11am
8-K
EX-99.1
nxr4k5x9wg8z y7s8
11 Dec 20
Oncternal Therapeutics Announces $40.0 Million Bought Deal Offering
6:11am
8-K
EX-99.1
khqu45oqqw
31 Aug 20
Oncternal Therapeutics Announces $3.5 Million Bought Deal Offering
4:33pm
8-K
EX-99.2
5w59934xr 0yv8wvac9
31 Aug 20
Oncternal Therapeutics Announces $3.5 Million Bought Deal Offering
4:33pm
FWP
xoqqczmx3qd2czlttgvy
27 Aug 20
Free writing prospectus
9:34pm
FWP
lh3v9z0fjddial0
18 Nov 20
Free writing prospectus
6:05am
8-K
EX-10.1
to2pe86ek2wk k3p
14 Dec 06
Entry into a Material Definitive Agreement
12:00am
FWP
yuyxd786nwxbupsiz6b
10 Dec 20
Free writing prospectus
6:11am
8-K
iy0zr1imiumpm o1
2 Mar 11
Termination of a Material Definitive Agreement
12:00am
8-K
EX-10.2
403hxb 2lx7u2
21 May 20
Oncternal Therapeutics Announces $5.0 Million Registered Direct Offering
4:31pm
425
EX-2.5
wrhdsry9iiyan7t9
7 Mar 19
Business combination disclosure
7:31am